DK3452050T3 - COMPOSITION COMPRISING HMOS FOR THE TREATMENT OF NONINFECTIOUS DIARRHOEA - Google Patents

COMPOSITION COMPRISING HMOS FOR THE TREATMENT OF NONINFECTIOUS DIARRHOEA Download PDF

Info

Publication number
DK3452050T3
DK3452050T3 DK17792540.1T DK17792540T DK3452050T3 DK 3452050 T3 DK3452050 T3 DK 3452050T3 DK 17792540 T DK17792540 T DK 17792540T DK 3452050 T3 DK3452050 T3 DK 3452050T3
Authority
DK
Denmark
Prior art keywords
hmos
noninfectious
diarrhoea
treatment
composition
Prior art date
Application number
DK17792540.1T
Other languages
Danish (da)
Inventor
Emma Elison
Bruce Mcconnell
Louise Kristine Vigsnaes
Original Assignee
Glycom As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=60202765&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK3452050(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US15/147,112 external-priority patent/US20160243138A1/en
Application filed by Glycom As filed Critical Glycom As
Application granted granted Critical
Publication of DK3452050T3 publication Critical patent/DK3452050T3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/125—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Mycology (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nutrition Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pediatric Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
DK17792540.1T 2016-05-05 2017-05-05 COMPOSITION COMPRISING HMOS FOR THE TREATMENT OF NONINFECTIOUS DIARRHOEA DK3452050T3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US15/147,112 US20160243138A1 (en) 2014-10-29 2016-05-05 Composition comprising HMSs/HMOs and use thereof
PCT/DK2017/050145 WO2017190754A1 (en) 2016-05-05 2017-05-05 Composition comprising hmos for the treatment of non-infectious diarrhoea

Publications (1)

Publication Number Publication Date
DK3452050T3 true DK3452050T3 (en) 2023-02-20

Family

ID=60202765

Family Applications (1)

Application Number Title Priority Date Filing Date
DK17792540.1T DK3452050T3 (en) 2016-05-05 2017-05-05 COMPOSITION COMPRISING HMOS FOR THE TREATMENT OF NONINFECTIOUS DIARRHOEA

Country Status (5)

Country Link
EP (1) EP3452050B1 (en)
DK (1) DK3452050T3 (en)
ES (1) ES2938355T3 (en)
PL (1) PL3452050T3 (en)
WO (1) WO2017190754A1 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10881674B2 (en) 2014-12-08 2021-01-05 Glycom A/S Synthetic composition for treating metabolic disorders
DK3452050T3 (en) 2016-05-05 2023-02-20 Glycom As COMPOSITION COMPRISING HMOS FOR THE TREATMENT OF NONINFECTIOUS DIARRHOEA
JP7327724B2 (en) 2017-11-30 2023-08-16 グリコム・アクティーゼルスカブ A mixture of HMOs to treat wheat sensitivity
EP3790997A4 (en) * 2018-05-09 2022-03-16 Carbiotix AB Method for measuring and improving gut health
WO2020128947A1 (en) * 2018-12-19 2020-06-25 Glycom A/S Composition and method for treating humans using low-fodmap diets
US20220022515A1 (en) 2019-02-25 2022-01-27 Nutribam Bv Composition, Food Supplement and Method for Supporting and/or Improving Intestinal Health
BE1027078A9 (en) * 2019-02-25 2020-09-28 Nutribam Bvba COMPOSITION, NUTRITIONAL SUPPLEMENT AND PROCEDURE FOR SUPPORTING AND / OR IMPROVING GUT HEALTH
JP2023503541A (en) * 2019-11-27 2023-01-31 グリコム・アクティーゼルスカブ mixture of HMOs
WO2022223430A1 (en) * 2021-04-19 2022-10-27 Dsm Ip Assets B.V. A composition of enzymes and human milk oligosaccharides
CN117286078B (en) * 2023-11-21 2024-02-02 四川厌氧生物科技有限责任公司 Lactobacillus plantarum for improving gastrointestinal health and application thereof

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2796082B1 (en) 1999-07-07 2003-06-27 Centre Nat Rech Scient PROCESS FOR PRODUCING OLIGOSACCHARIDES
CA2645141C (en) 2006-03-09 2018-07-10 Centre National De La Recherche Scientifique (Cnrs) Method of producing sialylated oligosaccharides
WO2010100979A1 (en) 2009-03-05 2010-09-10 日産自動車株式会社 Bipolar secondary cell and method for producing the same
US8927698B2 (en) 2009-04-07 2015-01-06 Glycom A/S Method for the synthesis of a trisaccharide
CN102803282A (en) 2010-02-19 2012-11-28 格礼卡姆股份公司 A method for preparation of the tetrasaccharide lacto-N-neotetraose (lNNT) containing N-acetyllactosamine
RU2013106897A (en) 2010-07-16 2014-08-27 Глюком А/С PRODUCTION OF OLIGOSACCHARIDES DERIVATIVES
US11337990B2 (en) * 2010-12-31 2022-05-24 Abbott Laboratories Human milk oligosaccharides to promote growth of beneficial bacteria
BR112013016914A2 (en) * 2010-12-31 2019-09-24 Abbott Lab symbiotic combination of probiotics and oligosaccharides from human milk to promote beneficial microbiota growth
US20140057868A1 (en) 2011-02-21 2014-02-27 Glycom A/S Catalytic hydrogenolysis of a composition of a mixture of oligosaccharide precursors and uses thereof
CN103443113A (en) 2011-03-18 2013-12-11 格力康公司 Synthesis of new fucose-containing carbohydrate derivatives
BR112013029208A2 (en) 2011-05-13 2017-02-14 Glycom As method for preparing one or more human milk oligosaccharides or derivatives or precursors therefor, use of oligosaccharides, and, compound
DK2707380T3 (en) 2011-05-13 2020-10-12 Glycom As DIVERSIFICATION OF HUMAN MILK OLIGOSACCHARIDES (HMOs) OR THEREOF PRECURSORS
EP2712362A4 (en) 2011-05-13 2014-12-24 Glycom As Manufacture of lacto-n-tetraose
MY169326A (en) * 2011-08-29 2019-03-21 Abbott Lab Human milk oligosaccharides for preventing injury and/or promoting healing of the gastrointestinal tract
US20140235850A1 (en) 2011-09-30 2014-08-21 Glycom A/S Synthesis of hmo core structures
WO2013091660A1 (en) 2011-12-23 2013-06-27 Glycom A/S A method for obtaining crystalline lacto-n-tetraose and lacto-n-neotetraose precursors and mixtures thereof
WO2013139344A1 (en) 2012-03-20 2013-09-26 Glycom A/S Synthesis of the trisaccharide 3-o-fucosyllactose and intermediates thereof
JP2015512936A (en) * 2012-04-13 2015-04-30 トラスティーズ オブ ボストン カレッジ Prebiotic composition and method of use thereof
US20150119360A1 (en) * 2012-04-23 2015-04-30 Kyoto University Composition for promoting bifidobacteria growth
EP3082828B1 (en) 2013-11-15 2022-03-02 Société des Produits Nestlé S.A. Compositions for use in the prevention or treatment of necrotizing enterocolitis in infants or young children born by c-section
WO2015095747A1 (en) 2013-12-20 2015-06-25 Abbott Laboratories Oral rehydration composition with oligosaccharides
US20170216328A1 (en) 2014-04-04 2017-08-03 Ritter Pharmaceuticals, Inc. Methods and compositions for microbiome alteration
CA3179163A1 (en) * 2014-04-08 2015-10-15 Abbott Laboratories Methods for enhancing mucosal innate immune responses to and/or detection of pathogens using human milk oligosaccharides
EP3212197A4 (en) * 2014-10-29 2018-07-11 Glycom A/S Synthetic composition and method for treating irritable bowel syndrome
MA41020A (en) 2014-11-25 2017-10-03 Evelo Biosciences Inc PROBIOTIC AND PREBIOTIC COMPOSITIONS, AND THEIR METHODS OF USE FOR MODULATION OF THE MICROBIOME
ES2975018T3 (en) 2015-11-17 2024-07-02 Glycom As Human milk oligosaccharides for the treatment of antibiotic-associated complications
DK3452050T3 (en) 2016-05-05 2023-02-20 Glycom As COMPOSITION COMPRISING HMOS FOR THE TREATMENT OF NONINFECTIOUS DIARRHOEA

Also Published As

Publication number Publication date
ES2938355T3 (en) 2023-04-10
EP3452050A4 (en) 2020-01-08
PL3452050T3 (en) 2023-06-12
EP3452050A1 (en) 2019-03-13
WO2017190754A1 (en) 2017-11-09
EP3452050B1 (en) 2022-11-23

Similar Documents

Publication Publication Date Title
DK3452050T3 (en) COMPOSITION COMPRISING HMOS FOR THE TREATMENT OF NONINFECTIOUS DIARRHOEA
IL253945B (en) Kdm1a inhibitors for the treatment of disease
MA44702A (en) EXTENDED-RELEASE SUSPENSION COMPOSITIONS
DK3466432T3 (en) PROCEDURES FOR THE TREATMENT OF PULMONAL NON-TUBERCULOSE MICOBACTERIAL INFECTIONS
DK3474804T4 (en) MEDICAL COMPOUND
BR112016021682A2 (en) cenicriviroc for the treatment of fibrosis
DK3240612T3 (en) PROCEDURES FOR THE TREATMENT OF RHINTH DISEASES
DK3362066T3 (en) COMBINATION THERAPY FOR THE TREATMENT OF MALIGNITIES
DK3524255T3 (en) COMPOSITION FOR THE TREATMENT OF ACNE
DK3265087T3 (en) PROCEDURE FOR TRADIPITANT TREATMENT
KR20180084853A (en) Hemostatic composition
DK3307267T3 (en) TREATMENT OF MULTIPLE SHELLOSIS
DK3261661T3 (en) MENOTROPIN FOR THE TREATMENT OF INFERTILITY
DK3373931T3 (en) Heterocyclic compounds for the treatment of disease
DK3302573T3 (en) COMPOSITION FOR THE TREATMENT OF BRAIN LESSIONS
DK3294769T3 (en) TREATMENT FOR MULTIPLE MYELOM (MM)
DK3169405T3 (en) METHODS, COMPOUNDS AND COMPOSITIONS FOR THE TREATMENT OF MUSCULOSKELETAL DISEASES
DK3331610T3 (en) Agents for the treatment of glioma
BR112016024667A2 (en) improved coating compositions and processes for the manufacture thereof
DK3484475T3 (en) 1-METHYLNICOTINAMIDE FOR THE TREATMENT OF CARDIOVASCULAR DISEASE
IT201600121617A1 (en) COMPOSITION FOR THE TREATMENT OF GASTROESOFAGEO REFLUX
DK3096775T3 (en) SOCS mimetics for the treatment of diseases
KR20180084983A (en) Uses of Pyrimido-Pyrimidazinone for the Treatment of Cancer
DK3352735T3 (en) OLANZAP EXTENDED-RELEASE DISCLOSURES
DK3548006T3 (en) COMPOSITION FOR THE TREATMENT OF INTESTINAL CHANGES